Baseline characteristics
obesity, pneumonia, malignancy, Pneumonia, hypertension, diabetes
OBESITY, PNEUMONIA, PNEUMONIA, HYPERTENSION, DIABETES
There was no difference in participants between the CCP and sotrovimab groups in age, gender, variant of concern, body mass index, duration from the onset of symptoms to treatment, vaccination status, pneumonia, cycle threshold value from PCR, and inflammatory markers. Almost all high-risk comorbidities were not different in both groups; however, hypertension was predominated at 61.8% in CPT and 42.7% in the sotrovimab group.The age of more than 60 years was 66.1% in CPT and 69.8% in the sotrovimab arm. The most common comorbidities were diabetes, obesity, and malignancy. The omicron BA.2 sublineage was predominated in both groups, despite 60% unknown variants in both arms. The mean duration from the onset of symptoms to randomization was 2 days. Unvaccinated presented 15% vs 25% in CPT and sotrovimab, respectively. Pneumonia was presented in 30% of both arms (Baseline characteristics of participantsPearson chi-squared test.Fisher’s exact test.Independent Mann–Whitney Categorical data are depicted as the number and percentage of participants. Continuous data are displayed as the mean ± standard deviation.
